Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CHE
CRSP
Add up to 3 more stocks
CHE
Chemed Corporation
+0.91%
$507.50+4.60Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$6.63B
52W Range
$365.21 - $557.00
CRSP
CRISPR Therapeutics AG
-0.02%
$55.43-0.01Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$5.35B
52W Range
$44.12 - $78.48
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 25.48 | N/A |
| Forward P/E | 19.91 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 7.99 | 3.06 |
| P/S Ratio | 2.56 | 399.21 |
| P/FCF Ratio | 20.50 | N/A |
| EV/EBITDA | 16.65 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 30.4% | -6537.0% |
| Operating Margin | 13.5% | -16191.4% |
| Net Margin | 10.6% | -3368.7% |
| ROE | 33.1% | -25.8% |
| ROA | 17.4% | -17.0% |
| ROIC | 19.5% | -21.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.91 | 17.85 |
| Quick Ratio | 0.89 | 17.85 |
| Debt/Equity | 0.40 | 0.45 |
| Interest Coverage | 193.28 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 0.5% | N/A |
| Payout Ratio | 12.6% | N/A |
| Yrs of Dividend Growth | 17 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.